BLOOMINGTON, Ind. -- Cook Inc. announces that the Food and Drug Administration (FDA) has cleared the company's new five-lumen central venous catheter designed to both improve multiple treatment administration and provide increased protection against hospital-based catheter-related bloodstream infections (CRBSIs).
This latest version of the Cook Spectrum catheter incorporates five separate, non-communicating vascular access lumens within a single catheter body. The five-lumen design reduces the necessity of performing multiple venipunctures or multiple stopcock configurations using single-lumen catheters. This version allows access into the venous system via one access site, allowing simultaneous administration of medications and multiple treatments such as antibiotics, chemotherapy, infusion, blood sampling and monitoring.
As CRBSIs account for more than 28,000 patient deaths annually, the antibiotic-impregnated five-lumen Spectrum catheter serves a particularly important role for physicians and patients. Spectrum catheters employ Cook's patented antimicrobial impregnation process that provides protection on both the internal and external surfaces of the catheter.
"Today's announcement demonstrates our continued dedication and commitment to the ongoing innovation of the Cook Spectrum catheter," said Bruce Gingles, global leader of Cook Critical Care. "The enhanced design of the new five-lumen version offers physicians both an unparalleled combination of simplified treatment administration and critical infection prevention for their patients."
Source: Cook Inc.
Â
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.